Holen Sie sich die Stockscreener-App
20.30
6.14%
1.1575
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Hims & Hers shares rise as investors refocus on growth outlook despite recent data-breach disclosure - Quiver Quantitative
Hims & Hers Advances a Consumer-Centric Digital Health Platform - The Globe and Mail
Hims & Hers Health (NYSE:HIMS) Shares Gap UpHere's Why - MarketBeat
Hims & Hers says limited data stolen in social engineering attack - Cybersecurity Dive
Hims & Hers Health stock climbs as price remains inside $18.90–$20.90 range - Traders Union
Hims & Hers Faces Investor Scrutiny Ahead of Quarterly Earnings - AD HOC NEWS
Best Healthcare Stocks To Add to Your WatchlistApril 5th - MarketBeat
2026-04-05 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Hims & Hers Health, Inc. (HIMS) And Encourages Shareholders to Reach Out | NYSE:HIMS | Press Release - Stockhouse
Hims & Hers Health, Inc. (NYSE:HIMS) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Hims & Hers Health, Inc. (HIMS) stock price, news, quote and history - Yahoo Finance UK
Hims & Hers Health, Inc. (HIMS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Hims Data Breach Tests Trust As Valuation Gap Attracts Investors - Yahoo Finance
Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Dir - PharmiWeb.com
Novo partnership fuels long-term optimism for Hims & Hers Health, Inc. (HIMS) - MSN
Data Breach Alert: Edelson Lechtzin LLP Investigates Hims & Hers, Inc. Data Breach - GlobeNewswire Inc.
Data Breach Alert: Edelson Lechtzin LLP Investigates Hims & Hers, Inc. Data Breach - PR Newswire
Hims & Hers Health Faces Investor Lawsuit Over Alleged Misconduct - National Today
Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc.HIMS - Business Wire
Hims & Hers hack: Telehealth company reports customer support system breach - The American Bazaar
Barclays raises PT on Hims & Hers Health (HIMS) stock - MSN
HIMS Stock Gains As FDA Reportedly Moves Toward Lifting Restrictions On Peptides - Stocktwits
Healthcare Stocks To Watch TodayApril 3rd - MarketBeat
Hims & Hers warns of data breach after Zendesk support ticket breach - BleepingComputer
Hims and Hers reveal cyberattack — customer support system hacked and personal info stolen, here's what we know - TechRadar
Here is what to know beyond why Hims & Hers Health, Inc. (HIMS) is a trending stock - MSN
Hims & Hers' Valuations Back To EarthRobust Monetization Trends Deserve Reiterated Buy - Seeking Alpha
Hims & Hers Health stock price forecast: sideways consolidation likely as HIMS falls 3.53% - Traders Union
Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock - Yahoo Finance
HIMS stock gains as FDA reportedly moves toward lifting restrictions on peptides - MSN
AI for investors - MLQ.ai
Security Breach and Trade Policy Fears Weigh on Hims & Hers Stock - AD HOC NEWS
Should You Buy Hims Stock Today? - theglobeandmail.com
Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know - Yahoo Finance
Hims & Hers flags suspicious activity linked to third‑party customer service vendor - TradingView
Hims & Hers Data Breach Exposes Customer Service Records - Claim Depot
Building Better Health: AI as the Operating System for Care - Hims & Hers Newsroom
Broad selling pressure keeps Hims & Hers stock restrained after telehealth expansion news - Traders Union
Hims & Hers Health, Inc. (HIMS) Outperforms Broader Market: What You Need to Know - MSN
US FDA clarifies policies on compounding of GLP-1 medicines - Reuters
Hims & Hers Health Inc (HIMS) Stock Price, Trades & News - GuruFocus
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm - globenewswire.com
Hims & Hers Health Stock Short Interest Falls to 45.18% - Quiver Quantitative
-3.88% for Hims & Hers Health stock as oscillators give mixed signals near session low - Traders Union
Hims & Hers Stock Is Down 63% Over the Past 6 Months. Here’s Why the Valuation Still Looks Compelling - TIKR.com
Novo Partnership Fuels Long-Term Optimism for Hims & Hers Health, Inc. (HIMS) - Insider Monkey
Hims & Hers expands personalized digital healthcare platform - MSN
Hims & Hers Broadens Tailored Online Health Services Platform - Bitget
Hims & Hers Expands Personalized Digital Healthcare Platform - The Globe and Mail
Hims & Hers Health Inc (HIMS) Stock Price Up 6.42% on Mar 31 - GuruFocus
HIMS Gains as FDA Revisits Rules on Compounding Pharmacies - GuruFocus
Did Hims & Hers' Novo Nordisk GLP-1 Partnership Just Shift Hims & Hers Health's (HIMS) Investment Narrative? - Sahm
Hims Novo Nordisk GLP-1 Launch Ties Growth Story To Valuation Gap - simplywall.st
Hims & Hers Health, Inc. (HIMS) registers a bigger fall than the market: Important facts to note - MSN
HIMS Sees Moderate Bearish Sentiment Among Option Traders - GuruFocus
Hims & Hers Health, Inc. (HIMS) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Hims & Hers Health Options Spot-On: On March 30th, 88,151 Contracts Were Traded, With 1.15 Million Open Interest - Moomoo
Assessing Hims & Hers Health (HIMS) Valuation After A Sharp Pullback And Long Term Shareholder Gains - Sahm
HIMS stock in spotlight after Hims & Hers adds Novo’s GLP-1 treatments to its platform - MSN
1.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):